Who backs SpyGlass Pharma (NAS: SGP)?
7 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| New Enterprise Associates | Venture capital |
| Sands Capital | Growth equity |
| Samsara BioCapital | Venture capital |
| Gilde Healthcare | PE / buyout |
| Vensana Capital | — |
| Vertex Ventures HC | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
SpyGlass Pharma (NAS: SGP) investors
7 investors are on record for SpyGlass Pharma (NAS: SGP), including RA Capital Management, New Enterprise Associates, Sands Capital and Samsara BioCapital. The Series D in Jun 2025 drew 6 investors.
Free account
More of SpyGlass Pharma (NAS: SGP) with a free account
- ·Watch SpyGlass Pharma (NAS: SGP): the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 7 firms already write checks for companies like SpyGlass Pharma (NAS: SGP) in surgical devices. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View